Keyphrases
GABAA Receptor (GABAAR)
100%
Modulatory Effects
100%
Efavirenz
100%
High Concentration
18%
Human Immunodeficiency Virus Type 1 (HIV-1)
9%
In(III)
9%
AIDS/HIV
9%
Recombinant
9%
Molecular Mechanism
9%
Ion Channels
9%
Inhibitory Effect
9%
Virus
9%
On-state Current
9%
Subunit Composition
9%
GABA Concentration
9%
Positive Allosteric Modulation
9%
Threonine
9%
Allosteric Site
9%
Phenylalanine
9%
Extracellular Domain
9%
Prescription Drugs
9%
Single-unit Recording
9%
Combination Therapy
9%
Transmembrane Domain
9%
Conserved Residues
9%
Potentiating Effect
9%
Dual Effect
9%
Pathogenic Strains
9%
Neuroscience
GABAA Receptor
100%
Efavirenz
100%
Gamma-Aminobutyric Acid
45%
Receptor
27%
Human Immunodeficiency Virus
18%
Ion Channel
9%
Protein Quaternary Structure
9%
Allosteric Site
9%
Phenylalanine
9%
Threonine
9%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Efavirenz
100%
4 Aminobutyric Acid
45%
Human Immunodeficiency Virus 1
9%
HIV
9%
Ion Channel
9%
Combination Therapy
9%
Threonine
9%
Phenylalanine
9%
Acquired Immune Deficiency Syndrome
9%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Whole Cell Patch Clamp
50%
Protein Quaternary Structure
50%
Allosteric Site
50%
Acquired Immune Deficiency Syndrome
50%